Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Ann Surg

Retrieve available abstracts of 162 articles:
HTML format

Single Articles

    May 2024
  1. KE L, Ye B, Huang M, Chen T, et al
    Balanced Solution versus Normal Saline in Predicted Severe Acute Pancreatitis: A Stepped Wedge Cluster Randomized Trial.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006319.
    PubMed     Abstract available

  2. SCHOUTEN TJ, Kroon VJ, Besselink MG, Bosscha K, et al
    Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic Cancer.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006320.
    PubMed     Abstract available

  3. MALLEO G, Lionetto G, Crippa S, Qadan M, et al
    Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322.
    PubMed     Abstract available

  4. JAMES P, Kaushal D, Beaumont Wilson R
    NETosis in Surgery: Pathophysiology, Prevention, and Treatment.
    Ann Surg. 2024;279:765-780.
    PubMed     Abstract available

    April 2024
  5. GAUJOUX S, Regimbeau JM, Piessen G, Truant S, et al
    Somatostatin vs. Octreotide for Prevention of Postoperative Pancreatic Fistula The PREFIPS Randomized Clinical Trial A FRENCH 007 - ACHBT Study.
    Ann Surg. 2024 Apr 25. doi: 10.1097/SLA.0000000000006313.
    PubMed     Abstract available

  6. ECKHOFF AM, Fletcher AA, Kelly MS, Dohlman A, et al
    Comprehensive Assessment of the Intrinsic Pancreatic Microbiome.
    Ann Surg. 2024 Apr 16. doi: 10.1097/SLA.0000000000006299.
    PubMed     Abstract available

  7. HABIB JR, Rompen IF, Kaslow SR, Grewal M, et al
    Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective Analysis.
    Ann Surg. 2024 Apr 12. doi: 10.1097/SLA.0000000000006295.
    PubMed     Abstract available

  8. BRADA LJH, Schouten TJ, Daamen LA, Seelen LWF, et al
    Evaluation of Short- and Long-Term Outcomes After Resection in Patients with Locally Advanced versus (Borderline) Resectable Pancreatic Cancer.
    Ann Surg. 2024 Apr 1. doi: 10.1097/SLA.0000000000006289.
    PubMed     Abstract available

    March 2024
  9. LUCOCQ J, Halle-Smith J, Haugk B, Joseph N, et al
    Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
    Ann Surg. 2024 Mar 22. doi: 10.1097/SLA.0000000000006272.
    PubMed     Abstract available

  10. CASS SH, Tzeng CD, Prakash LR, Maxwell J, et al
    Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Mar 20. doi: 10.1097/SLA.0000000000006269.
    PubMed     Abstract available

  11. CHEN H, Wang W, Fu N, Xia W, et al
    Characterization of Pancreatic Fistula after Post-pancreatectomy Acute Pancreatitis.
    Ann Surg. 2024 Mar 19. doi: 10.1097/SLA.0000000000006277.
    PubMed     Abstract available

    February 2024
  12. BOGGI U, Kauffmann E, Napoli N, Barreto SG, et al
    REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.
    Ann Surg. 2024 Feb 26. doi: 10.1097/SLA.0000000000006248.
    PubMed     Abstract available

  13. CHEN H, Wang Y, Jiang K, Xu Z, et al
    The Effect of Perioperative Dexamethasone on Postoperative Complications after Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2024 Feb 22. doi: 10.1097/SLA.0000000000006240.
    PubMed     Abstract available

  14. LI L, Zhang Q, Feng Y, Kong F, et al
    A Novel Serum Exosomal miRNA Signature in the Early Prediction of Persistent Organ Failure in Patients with Acute Pancreatitis.
    Ann Surg. 2024 Feb 7. doi: 10.1097/SLA.0000000000006229.
    PubMed     Abstract available

  15. PERRI G, Romandini E, Marchegiani G, Ghorbani P, et al
    Postoperative Hyperamylasemia (POH) is an Early Predictor of Pancreatic Fistula Occurrence and Severity after Distal Pancreatectomy: Results from a European Multicentric Study.
    Ann Surg. 2024 Feb 2. doi: 10.1097/SLA.0000000000006222.
    PubMed     Abstract available

    January 2024
  16. STEIN-THOERINGER CK, Renz BW, De Castilhos J, von Ehrlich-Treuenstatt V, et al
    Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Jan 26. doi: 10.1097/SLA.0000000000006210.
    PubMed     Abstract available

  17. OU H, Chen M, Qin K, Zhao S, et al
    Short-term and Long-term Outcomes of Robotic Enucleation of Tumors Located in the Pancreatic Head and Uncinate Process.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006198.
    PubMed     Abstract available

  18. SHAH D, Wells A, Cox M, Dawravoo K, et al
    Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006209.
    PubMed     Abstract available

  19. KOTECHA K, Tree K, Ziaziaris WA, McKay SC, et al
    Centralization of Pancreaticoduodenectomy: A Systematic Review and Spline Regression Analysis to Recommend Minimum Volume for a Specialist Pancreas Service.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006208.
    PubMed     Abstract available

  20. ASSAWASIRISIN C, Qadan M, Aimprasittichai S, Kambadakone A, et al
    Pancreatic Serous Cystadenoma: A Continuing Diagnostic Challenge.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006203.

  21. NICKEL F, Kuemmerli C, Muller PC, Schmidt MW, et al
    The PAncreatic Surgery Composite Endpoint PACE - Development and Validation of a Clinically Relevant Endpoint Requiring Lower Sample Sizes.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006194.
    PubMed     Abstract available

  22. MALLEO G, Casciani F, Lionetto G, Esposito A, et al
    Resection to Exploration Ratios and Associated Outcomes in Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006197.
    PubMed     Abstract available

    December 2023
  23. VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Dekker EN, et al
    Nationwide Outcome of Tailored Surgery for Symptomatic Chronic Pancreatitis based on Pancreatic Morphology: Validation of the International guidelines.
    Ann Surg. 2023 Dec 13. doi: 10.1097/SLA.0000000000006176.
    PubMed     Abstract available

  24. THEIJSE RT, Stoop TF, Hendriks TE, Suurmeijer JA, et al
    Nationwide Outcome after Pancreatoduodenectomy in Patients at very High Risk (ISGPS-D) for Postoperative Pancreatic Fistula.
    Ann Surg. 2023 Dec 11. doi: 10.1097/SLA.0000000000006174.
    PubMed     Abstract available

  25. ZHU X, Xiao Z, Liu H, Zhang P, et al
    Pancreatic Cancer: An Exocrine Tumor with Endocrine Characteristics.
    Ann Surg. 2023 Dec 5. doi: 10.1097/SLA.0000000000006168.
    PubMed     Abstract available

  26. CRIPPA S, Malleo G, Langella S, Ricci C, et al
    Cure Probabilities After Resection Of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis Of 2554 Patients.
    Ann Surg. 2023 Dec 4. doi: 10.1097/SLA.0000000000006166.
    PubMed     Abstract available

  27. PERRI G, Marchegiani G, Partelli S, Andreasi V, et al
    Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy.
    Ann Surg. 2023;278:e1242-e1249.
    PubMed     Abstract available

    November 2023
  28. QIN T, Zhang H, Pan S, Liu J, et al
    Effect of Laparoscopic and Open Pancreatoduodenectomy for Pancreatic or Periampullary Tumors: Three-year Follow-up of a Randomized Clinical Trial.
    Ann Surg. 2023 Nov 15. doi: 10.1097/SLA.0000000000006149.
    PubMed     Abstract available

  29. VERMA A, Balian J, Hadaya J, Premji A, et al
    Machine Learning Based Prediction of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy.
    Ann Surg. 2023 Nov 10. doi: 10.1097/SLA.0000000000006123.
    PubMed     Abstract available

  30. PULVIRENTI A, Javed AA, Michelakos T, Sekigami Y, et al
    Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
    Ann Surg. 2023;278:e1063-e1067.
    PubMed     Abstract available

    October 2023
  31. ROMPEN IF, Levine J, Habib JR, Sereni E, et al
    Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment.
    Ann Surg. 2023 Oct 23. doi: 10.1097/SLA.0000000000006142.
    PubMed     Abstract available

  32. FUCHS J, Loos M, Kinny-Koster B, Hackert T, et al
    Pancreatic Surgery in Children: Complex, Safe and Effective.
    Ann Surg. 2023 Oct 17. doi: 10.1097/SLA.0000000000006125.
    PubMed     Abstract available

  33. QIAO G, Fong ZV, Bolm L, Fernandez Del-Castillo C, et al
    Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2023 Oct 13. doi: 10.1097/SLA.0000000000006131.
    PubMed     Abstract available

    September 2023
  34. PAIELLA S, Secchettin E, Lionetto G, Archibugi L, et al
    Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence meta-analysis to Estimate the Rate of low-yield Surgery.
    Ann Surg. 2023 Sep 8. doi: 10.1097/SLA.0000000000006094.
    PubMed     Abstract available

    August 2023
  35. IMAMURA T, Ohgi K, Mori K, Ashida R, et al
    Surrogacy of Recurrence-free Survival for Overall Survival as an Endpoint of Clinical Trials of Perioperative Adjuvant Therapy in Hepatobiliary-pancreatic Cancers: A Retrospective Study and Meta-analysis.
    Ann Surg. 2023 Aug 28. doi: 10.1097/SLA.0000000000006084.
    PubMed     Abstract available

  36. VAN DONGEN JC, van Dam JL, Besselink MG, Bonsing BA, et al
    Fistula Risk Score for Auditing Pancreatoduodenectomy: The Auditing-FRS.
    Ann Surg. 2023;278:e272-e277.
    PubMed     Abstract available

    July 2023
  37. ZHANG C, Zironda A, Vierkant RA, Starlinger P, et al
    Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy.
    Ann Surg. 2023 Jul 27. doi: 10.1097/SLA.0000000000006053.
    PubMed     Abstract available

  38. SEELEN LWF, Doppenberg D, Stoop TF, Nagelhout A, et al
    Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients with Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006021.
    PubMed     Abstract available

  39. MARCINIAK C, Lenne X, Bruandet A, Hamroun A, et al
    Risk-Benefit Balance of Simultaneous Gastric Bypass or Sleeve Gastrectomy and Concomitant Cholecystectomy: A Comprehensive Nationwide Cohort of 289,627 Patients.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006039.
    PubMed     Abstract available

  40. PECORELLI N, Guarneri G, Vallorani A, Limongi C, et al
    Validation of the PROMIS-29 Questionnaire as a Measure of Recovery after Pancreatic Surgery.
    Ann Surg. 2023 Jul 19. doi: 10.1097/SLA.0000000000006020.
    PubMed     Abstract available

  41. VAN GOOR IWJM, Schouten TJ, Verburg DN, Besselink MG, et al
    Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006004.
    PubMed     Abstract available

  42. VAN VELDHUISEN CL, Sissingh NJ, Boxhoorn L, van Dijk SM, et al
    Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER): Multicenter Randomized Trial.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006001.
    PubMed     Abstract available

  43. PODDA M, Di Martino M, Ielpo B, Catena F, et al
    The 2023 MANCTRA Acute Biliary Pancreatitis Care Bundle: A Joint Effort Between Human Knowledge and Artificial Intelligence (ChatGPT) to Optimize the Care of Patients With Acute Biliary Pancreatitis in Western Countries.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006008.
    PubMed     Abstract available

  44. ABU HILAL M, van Ramshorst TME, Boggi U, Dokmak S, et al
    The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS).
    Ann Surg. 2023 Jul 14. doi: 10.1097/SLA.0000000000006006.
    PubMed     Abstract available

  45. VAN OOSTEN AF, Groot VP, Dorland G, Burkhart RA, et al
    Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection.
    Ann Surg. 2023 Jul 3. doi: 10.1097/SLA.0000000000005977.
    PubMed     Abstract available

  46. LOOS M, Konig AK, von Winkler N, Mehrabi A, et al
    Completion Pancreatectomy After Pancreatoduodenectomy: Who Needs It?
    Ann Surg. 2023;278:e87-e93.
    PubMed     Abstract available

    June 2023
  47. SNYDER RA, Dueck AC, Fruth B, Shi Q, et al
    Patient-Reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
    Ann Surg. 2023 Jun 19. doi: 10.1097/SLA.0000000000005958.
    PubMed     Abstract available

  48. PULVIRENTI A, Hauser HF, Fiedler LM, McIntyre CA, et al
    Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
    Ann Surg. 2023 Jun 16. doi: 10.1097/SLA.0000000000005941.
    PubMed     Abstract available

  49. ELLIS RJ, Brajcich BC, Bertens KA, Chan CHF, et al
    Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
    Ann Surg. 2023 Jun 14. doi: 10.1097/SLA.0000000000005955.
    PubMed     Abstract available

    May 2023
  50. SUGAWARA T, Rodriguez Franco S, Sherman S, Torphy RJ, et al
    Neoadjuvant Chemotherapy versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
    Ann Surg. 2023 May 25. doi: 10.1097/SLA.0000000000005925.
    PubMed     Abstract available

  51. NIKIFOROVA MN, Wald AI, Spagnolo DM, Melan MA, et al
    A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising from Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005904.
    PubMed     Abstract available

  52. ARMSTRONG MT, Saadat LV, Chou JF, Gonen M, et al
    Risk Factors for Progression in Patients Undergoing Surveillance for Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005922.
    PubMed     Abstract available

  53. STOOP TF, Bergquist E, Theijse RT, Hempel S, et al
    Systematic review and Meta-analysis of the Role of total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: is it a Justifiable Indication?
    Ann Surg. 2023 May 9. doi: 10.1097/SLA.0000000000005895.
    PubMed     Abstract available

    April 2023
  54. THALJI SZ, Fernando D, Dua KS, Madhavan S, et al
    Biliary Adverse Events during Neoadjuvant Therapy for Pancreatic Cancer.
    Ann Surg. 2023 Apr 20. doi: 10.1097/SLA.0000000000005884.
    PubMed     Abstract available

  55. TAKAHASHI H, Akita H, Wada H, Miyata H, et al
    Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients with Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Sett
    Ann Surg. 2023 Apr 14. doi: 10.1097/SLA.0000000000005879.
    PubMed     Abstract available

  56. ELSHAMI M, Ammoun AK, Mneimneh WS, Stitzel HJ, et al
    Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association with Adverse Survival Outcomes: A Single-institution Analysis.
    Ann Surg. 2023 Apr 13. doi: 10.1097/SLA.0000000000005870.
    PubMed     Abstract available

  57. LEONHARDT CS, Pils D, Qadan M, Jomrich G, et al
    The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment.
    Ann Surg. 2023 Apr 12. doi: 10.1097/SLA.0000000000005874.
    PubMed     Abstract available

  58. NGO-HUANG AT, Parker NH, Xiao LC, Schadler KL, et al
    Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial.
    Ann Surg. 2023 Apr 7. doi: 10.1097/SLA.0000000000005878.
    PubMed     Abstract available

  59. VAN 'T LAND FR, Aziz MH, Michiels N, Mieog JSD, et al
    Increasing Systemic Immune-Inflammation Index During Treatment in Patients with Advanced Pancreatic Cancer is Associated with Poor Survival - A Retrospective, Multicenter, Cohort Study.
    Ann Surg. 2023 Apr 3. doi: 10.1097/SLA.0000000000005865.
    PubMed     Abstract available

    March 2023
  60. LOOS M, Khajeh E, Mehrabi A, Kinny-Koster B, et al
    Distal Pancreatectomy with En-bloc Celiac Axis Resection (dp-car) for Locally Advanced Pancreatic Cancer: A Safe And Effective Procedure.
    Ann Surg. 2023 Mar 30. doi: 10.1097/SLA.0000000000005866.
    PubMed     Abstract available

    February 2023
  61. LEE A, Al-Arnawoot A, Rajendran L, Lamb T, et al
    Feasibility and Safety of a "Shared Care" Model in Complex Hepatopancreatobiliary Surgery: A 5-Year Observational Study of Outcomes in Pancreaticoduodenectomy.
    Ann Surg. 2023 Feb 20. doi: 10.1097/SLA.0000000000005826.
    PubMed     Abstract available

  62. SCHOUTEN TJ, Henry AC, Smits FJ, Besselink MG, et al
    Risk Models for Developing Pancreatic Fistula after Pancreatoduodenectomy: Validation in a Nationwide Prospective Cohort.
    Ann Surg. 2023 Feb 20. doi: 10.1097/SLA.0000000000005824.
    PubMed     Abstract available

  63. DREYER SB, Rae S, Bisset K, Upstill-Goddard R, et al
    The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer.
    Ann Surg. 2023;277:e396-e405.
    PubMed     Abstract available

    January 2023
  64. LIANG T, Zhang Q, Wu G, Liu C, et al
    Radical Resection Combined with Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer after Neoadjuvant Therapy: A Report of 36 Consecutive Cases.
    Ann Surg. 2023 Jan 24. doi: 10.1097/SLA.0000000000005797.
    PubMed     Abstract available

  65. VAN DEN BROEK BLJ, Zwart MJW, Bonsing BA, Busch OR, et al
    Video Grading of Pancreatic Anastomoses During Robotic Pancreatoduodenectomy to Assess both Learning Curve and the Risk of Pancreatic Fistula - A Post Hoc Analysis of the LAELAPS-3 Training Program.
    Ann Surg. 2023 Jan 20. doi: 10.1097/SLA.0000000000005796.
    PubMed     Abstract available

  66. TIMMERHUIS HC, van den Berg FF, Noorda PC, van Dijk SM, et al
    Over- and Misuse of Antibiotics and the Clinical Consequence in Necrotizing Pancreatitis: An Observational Multicenter Study.
    Ann Surg. 2023 Jan 3. doi: 10.1097/SLA.0000000000005790.
    PubMed     Abstract available

    December 2022
  67. NEWHOOK TE, Vreeland TJ, Griffin JF, Tidwell RSS, et al
    Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
    Ann Surg. 2022 Dec 26. doi: 10.1097/SLA.0000000000005184.
    PubMed     Abstract available

  68. NISHIWADA S, Cui Y, Sho M, Jun E, et al
    Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022;276:e876-e885.
    PubMed     Abstract available

    November 2022
  69. KULKARNI S, Parina R, Henderson R, Derek E, et al
    Transfusion-Free Strategies in Liver and Pancreatic Surgery: A Predictive Model of Blood Conservation for Transfusion Avoidance in Mainstream Populations.
    Ann Surg. 2022 Nov 17. doi: 10.1097/SLA.0000000000005757.
    PubMed     Abstract available

  70. KASLOW SR, Sacks GD, Berman RS, Lee AY, et al
    Natural History of Stage IV Pancreatic Cancer. Identifying Survival Benchmarks for Curative-intent Resection in Patients With Synchronous Liver-only Metastases.
    Ann Surg. 2022 Nov 10. pii: 00000658-990000000-00312.
    PubMed     Abstract available

    September 2022
  71. BALZANO G, Zerbi A, Aleotti F, Capretti G, et al
    Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial.
    Ann Surg. 2022 Sep 30. pii: 00000658-990000000-00269.
    PubMed     Abstract available

  72. JAVED AA, Ding D, Hasanain A, van Oosten F, et al
    Persistent Circulating Tumor Cells at One Year after Oncologic Resection Predict Late Recurrence in Pancreatic Cancer.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00263.
    PubMed     Abstract available

  73. JAVED AA, Floortje van Oosten A, Habib JR, Hasanain A, et al
    A Delay in Adjuvant Therapy is Associated with Worse Prognosis only in Patients with Transitional Circulating Tumor Cells Following Resection of Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00264.
    PubMed     Abstract available

  74. DEMYAN L, Habowski AN, Plenker D, King DA, et al
    Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
    Ann Surg. 2022;276:450-462.
    PubMed     Abstract available

    August 2022
  75. KHACHFE HH, Nassour I, Hammad AY, Hodges JC, et al
    Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes - Is Laparoscopy Still Justified?
    Ann Surg. 2022 Aug 24. pii: 00000658-990000000-00239.
    PubMed     Abstract available

  76. ECKER BL, Dickinson SM, Saadat LV, Tao AJ, et al
    Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00228.
    PubMed     Abstract available

  77. SEELEN LWF, Floortje van Oosten A, Brada LJH, Groot VP, et al
    Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00226.
    PubMed     Abstract available

  78. PARTELLI S, Muffatti F, Andreasi V, Giannone F, et al
    A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2022 Aug 5. pii: 00000658-990000000-00213.
    PubMed     Abstract available

  79. WEI AC, Jarnagin WR
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria: Not So Simple.
    Ann Surg. 2022;276:222-223.

  80. BOLM L, Pisuchpen N, Qadan M, Kambadakone A, et al
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria.
    Ann Surg. 2022;276:215-221.
    PubMed     Abstract available

    July 2022
  81. MERDRIGNAC A, Garnier J, Dokmak S, Regenet N, et al
    Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula after Distal Pancreatectomy: Results of the REPLAY Multicenter Randomized clinical trial REPLAY: REinforcement of the Pancreas in distaL pAncreatectomY.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00185.
    PubMed     Abstract available

  82. BANNONE E, Marchegiani G, Vollmer C, Perri G, et al
    Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00182.
    PubMed     Abstract available

  83. TIMMERHUIS HC, van Dijk SM, Hollemans RA, Umans DS, et al
    Perforation and Fistula of the Gastrointestinal Tract in Patients with Necrotizing Pancreatitis: a Nationwide Prospective Cohort.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00174.
    PubMed     Abstract available

  84. SUURMEIJER JA, Henry AC, Bonsing BA, Bosscha K, et al
    Outcome of Pancreatic Surgery During the First Six Years of a Mandatory Audit within the Dutch Pancreatic Cancer Group.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00173.
    PubMed     Abstract available

  85. CHEN H, Wang C, Shen Z, Wang W, et al
    Post-pancreatectomy Acute Pancreatitis after Pancreaticoduodenectomy: A Distinct Clinical Entity.
    Ann Surg. 2022 Jul 18. pii: 00000658-990000000-00161.
    PubMed     Abstract available

  86. KINNY-KOSTER B, Habib JR, van Oosten AF, Javed AA, et al
    Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques and Graft Performance.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00153.
    PubMed     Abstract available

  87. POULSON MR, Papageorge MV, LaRaja AS, Kenzik KM, et al
    Socioeconomic Mediation of Racial Segregation in Pancreatic Cancer Treatment and Outcome Disparities.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00136.
    PubMed     Abstract available

  88. HACKERT T, Klaiber U, Hinz U, Strunk S, et al
    Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00058.
    PubMed     Abstract available

  89. YAO J, Cao K, Hou Y, Zhou J, et al
    Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer: A Retrospective Multicenter Study.
    Ann Surg. 2022 Jul 4. pii: 00000658-990000000-00053.
    PubMed     Abstract available

    June 2022
  90. CHINNAKOTLA S, Beilman GJ, Vock D, Freeman ML, et al
    Intraportal Islet Autotransplantation Independently Improves Quality of Life after Total Pancreatectomy in Patients with Chronic Refractory Pancreatitis.
    Ann Surg. 2022 Jun 28. pii: 00000658-990000000-00030.
    PubMed     Abstract available

  91. HANK T, Klaiber U, Hinz U, Schutte D, et al
    Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
    Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00016.
    PubMed     Abstract available

  92. BOLM L, Nebbia M, Wei AC, Zureikat AH, et al
    Long Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients with Non-Functional Pancreatic Neuroendocrine Tumors <3cm in a Large Multi-Center Cohort.
    Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00029.
    PubMed     Abstract available

    March 2022
  93. YAMAGUCHI J, Yokoyama Y, Fujii T, Yamada S, et al
    Results of a Phase II Study on the use of Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine with nab-paclitaxel) for Borderline-Resectable Pancreatic Cancer (NUPAT-01).
    Ann Surg. 2022 Mar 3. pii: 00000658-900000000-93060.
    PubMed     Abstract available

  94. DA COSTA WL JR, Tran Cao HS, Gu X, Massarweh NN, et al
    Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
    Ann Surg. 2022;275:415-421.
    PubMed     Abstract available

    Commentary on "Laparoscopic Pancreaticoduodenectomy With Transanal Specimen Extraction for Periampullary Tumors".
    Ann Surg. 2022;275:e599.

    February 2022
  96. BOECK S, Heinemann V, Werner J
    Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93084.

  97. DAAMEN LA, Groot VP, Verkooijen HM, Molenaar IQ, et al
    Response to: Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93083.

    January 2022
  98. JAVED AA, Pulvirenti A, Razi S, Zheng J, et al
    Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93105.
    PubMed     Abstract available

  99. OMIYA K, Oba A, Inoue Y, Kobayashi K, et al
    Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93098.
    PubMed     Abstract available

  100. Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study): A Multicenter Cohort Study: Erratum.
    Ann Surg. 2022;275:e280.

    December 2021
  101. JANSSEN BV, Verhoef S, Wesdorp NJ, Huiskens J, et al
    Imaging-based Machine-learning Models to Predict Clinical Outcomes and Identify Biomarkers in Pancreatic Cancer: A Scoping Review.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93137.
    PubMed     Abstract available

  102. LOPEZ-VERDUGO F, Fong ZV, Lillemoe KD, Blaszkowsky LS, et al
    Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93135.
    PubMed     Abstract available

  103. NAGAKAWA Y, Jang JY, Kawai M, Kim SC, et al
    Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93153.
    PubMed     Abstract available

  104. CLARKE CN, Maduekwe UN
    Commentary on Brief Clinical Report: "Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreaticoduodenectomy: A pilot series".
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93145.

  105. HUANG L, Jansen L, Balavarca Y, van der Geest L, et al
    Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Ann Surg. 2021;274:e554-e563.
    PubMed     Abstract available

    November 2021
  106. BEDNAR F
    Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93186.

  107. HUSCHER C, Perri G, Lazzarin G, Marchegiani G, et al
    Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreatoduodenectomy: A Pilot Series.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93185.
    PubMed     Abstract available

  108. GARAJOVA I, Balsano R, Donati V, Gnetti L, et al
    Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93189.

  109. DAYYEH BKA, Chandrasekhara V, Shah RJ, Easler JJ, et al
    Combined Drainage and Protocolized Necrosectomy Through a Co-axial Lumen-Apposing Metal Stent for Pancreatic Walled-off Necrosis: A Prospective Multicenter Trial.
    Ann Surg. 2021 Nov 2. pii: 00000658-900000000-93212.
    PubMed     Abstract available

    October 2021
  110. KEMPENEERS MA, Issa Y, Bruno MJ, van Santvoort HC, et al
    Cost-Effectiveness of Early Surgery Versus Endoscopy-First Approach for Painful Chronic Pancreatitis in the ESCAPE Trial.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93237.
    PubMed     Abstract available

  111. DALMACY D, Paro A, Hyer JM, Obeng-Gyasi S, et al
    Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93235.
    PubMed     Abstract available

    September 2021
  112. MARCHEGIANI G, Barreto SG, Bannone E, Sarr M, et al
    Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93261.
    PubMed     Abstract available

    August 2021
  113. LIU Q, Zhao Z, Zhang X, Wang W, et al
    Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93318.
    PubMed     Abstract available

  114. ROLDAN J, Harrison JM, Qadan M, Bolm L, et al
    "Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections".
    Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93359.
    PubMed     Abstract available

    July 2021
  115. BIRRER DL, Golcher H, Casadei R, Haile SR, et al
    Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93387.
    PubMed     Abstract available

  116. BEUGNIEZ C, Sauvanet A, Sulpice L, Gaujoux S, et al
    Root-Cause Analysis of Mortality Following Pancreatic Resection (CARE Study): A Multicenter Cohort Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93374.
    PubMed     Abstract available

  117. BRADA LJH, Daamen LA, Magermans LG, Walma MS, et al
    Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer Following Upfront FOLFIRINOX versus FOLFIRINOX Only: Multicenter Propensity Score-Matched Analysis.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93372.
    PubMed     Abstract available

  118. JOLISSAINT JS, Reyngold M, Bassmann J, Seier KP, et al
    Local Control and Survival after Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma with Vascular Involvement.
    Ann Surg. 2021 Jul 16. pii: 00000658-900000000-93409.
    PubMed     Abstract available

  119. MAATMAN TK, McGuire SP, Flick KF, Madison MK, et al
    Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93434.
    PubMed     Abstract available

  120. YEO TP, Fogg RW, Shimada A, Marchesani N, et al
    The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic.
    Ann Surg. 2021 Jul 2. pii: 00000658-900000000-93452.
    PubMed     Abstract available

  121. BLAIR AB, Yin LD, Pu N, Yu J, et al
    Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer.
    Ann Surg. 2021;274:162-169.
    PubMed     Abstract available

    June 2021
  122. HESTER CA, Kothari AN, Mason M, Maxwell J, et al
    Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients with Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93456.
    PubMed     Abstract available

  123. DAI M, Liu Q, Xing C, Tian X, et al
    Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial.
    Ann Surg. 2021 Jun 11. pii: 00000658-900000000-93510.
    PubMed     Abstract available

    April 2021
  124. BANNONE E, Marchegiani G, Balduzzi A, Procida G, et al
    Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity after Pancreatic Surgery.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93565.
    PubMed     Abstract available

  125. GIULIANI T, De Pastena M, Paiella S, Marchegiani G, et al
    Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.
    Ann Surg. 2021 Apr 14. pii: 00000658-900000000-93588.
    PubMed     Abstract available

  126. HABIB JR, Kinny-Koster B, Bou-Samra P, Alsaad R, et al
    Surgical Decision Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93602.
    PubMed     Abstract available

  127. MENG H, Wang S, Liu J, Zhao X, et al
    Laparoscopic Pancreaticoduodenectomy with Transanal Specimen Extraction for Periampullary Tumors.
    Ann Surg. 2021 Apr 7. pii: 00000658-900000000-93576.
    PubMed     Abstract available

  128. HACKERT T, Buchler MW
    Respone to: Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004872.

  129. LINDEMANN J, Toit LD, Krige J, Jonas E, et al
    Comment on: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004877.

    March 2021
  130. SCHUH F, Mihaljevic AL, Probst P, Trudeau MT, et al
    A Simple Classification Of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855.
    PubMed     Abstract available

  131. MARCHEGIANI G, Perri G, Burelli A, Zoccatelli F, et al
    High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004840.
    PubMed     Abstract available

  132. HANK T, Hinz U, Reiner T, Malleo G, et al
    A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004845.
    PubMed     Abstract available

    February 2021
  133. LOOS M, Hackert T, Buchler MW
    Response to Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93709.

  134. REAMES BN, Ejaz A, Weiss MJ
    Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93707.

    January 2021
  135. BEGER HG, Mayer B, Vasilescu C, Poch B, et al
    Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
    Ann Surg. 2021 Jan 15. doi: 10.1097/SLA.0000000000004757.
    PubMed     Abstract available

  136. VAN DEN BERG FF, Issa Y, Vreijling JP, Lerch MM, et al
    Whole-Exome Sequencing Identifies SLC52A1 and ZNF106 Variants as Novel Genetic Risk Factors for (Early) Multiple-Organ Failure in Acute Pancreatitis.
    Ann Surg. 2021;Publish Ahead of Print.
    PubMed     Abstract available

  137. ADDEO P, Averous G, Bachellier P
    Response to Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2021 Jan 1. pii: 00000658-900000000-93782.

    December 2020
  138. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.

  139. HEWITT DB, Nissen N, Hatoum H, Musher B, et al
    A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004669.
    PubMed     Abstract available

  140. GIBOR U, Perry Z, Netz U, Kirshtein B, et al
    Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time-A Prospective Cohort Study.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  141. SUGUMAR K, Hue JJ, Ahorukomeye P, Rothermel LD, et al
    Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies over the Past Decade.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  142. DE GEUS SWL, Hachey KJ, Nudel JD, Ng SC, et al
    Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004432.
    PubMed     Abstract available

  143. VERSTEIJNE E, Suker M, Groen JV, Besselink MG, et al
    External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible But Non-Randomized Patients.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004364.
    PubMed     Abstract available

    November 2020
  144. HUNGER R, Mantke R
    Outcome Quality Beyond the Mean - An Analysis of 43,231 Pancreatic Surgical Procedures Related to Hospital Volume.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004315.
    PubMed     Abstract available

  145. LOF S, Korrel M, Besselink MG, Abu Hilal M, et al
    Response to Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004279.

  146. CHEN B, Li G, Cheng W, Chen M, et al
    Comment On: Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004621.

  147. ZYROMSKI NJ, Maatman TK
    Response to Letter to Editor Regarding: "Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes" (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468).
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004622.

  148. ROBERTSON FP, Ravikumar R, Wigmore SJ
    Comment on: Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004536.

  149. ZHANG XP, Zhao GD, Liu R
    Comment On "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2020 Nov 16. doi: 10.1097/SLA.0000000000004410.

  150. RAMIREZ-MALDONADO E, Gordo SL, Pueyo EM, Sanchez-Garcia A, et al
    Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
    Ann Surg. 2020 Nov 13. doi: 10.1097/SLA.0000000000004596.
    PubMed     Abstract available

  151. VAN DONGEN JC, Suker M, Versteijne E, Bonsing BA, et al
    Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004313.
    PubMed     Abstract available

  152. MALLEO G, Maggino L, Qadan M, Marchegiani G, et al
    Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004552.
    PubMed     Abstract available

    October 2020
  153. HUANG L
    Response to the: Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients with Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004449.

  154. CRIPPA S, Pergolini I, Javed AA, Honselmann KC, et al
    Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004464.
    PubMed     Abstract available

  155. DATTA J, Wilson GC, D'Angelica MI, Katz MH, et al
    A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004471.

  156. MAATMAN TK, Ceppa EP, Fogel EL, Easler JJ, et al
    Biliary Stricture after Necrotizing Pancreatitis: An Underappreciated Challenge.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004470.
    PubMed     Abstract available

  157. CHAWLA A, Qadan M, Castillo CF, Wo JY, et al
    Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004585.
    PubMed     Abstract available

  158. XU HX, Li S, Xu SS, Liu L, et al
    Comments on "Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer".
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004538.

  159. TAKAHASHI S, Ohno I, Ikeda M, Konishi M, et al
    Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05).
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004535.
    PubMed     Abstract available

  160. SCHULICK RD, Oba A, Del Chiaro M
    Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004275.

    September 2020
  161. HU HJ, Cheng NS, Li FY
    Comment on: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2020 Sep 29. doi: 10.1097/SLA.0000000000004283.

    June 2020
  162. LOOS M, Kester T, Klaiber U, Mihaljevic AL, et al
    Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
    Ann Surg. 2020 Jun 12. doi: 10.1097/SLA.0000000000004054.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.